Beclomethasone Dipropionate Inhaler in the Treatment of the Non-infective Laryngitis in Professional Voice Users

Abstract

We report our experience using beclomethasone dipropionate inhaler (BDI), in the management of non-infective laryngitis and post-operative inflammation in singers and other professional voice users. This trial comprised ten cases of persisting non-infective laryngitis resulting from long term vocal abuse because of the nature of their occupations, and five cases of persisting post-operative vocal cord inflammation following laryngomicro surgery of vocal nodules. BDI was administered by oral spray in 50μg per puff, two puffs four times daily, totalling 400μg for two to four weeks. In all cases, symptoms and vocal cord inflammation markedly improved over the course of one week, and complaints of hoarseness virtually disappeared within two to four weeks. No side effects were noted. We believe that in those cases where long term therapy employing absolute silence is impractical or unsatisfactory, BDI is a useful therapeutic adjunct in noninfective laryngitis.